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Purpose of review: Current research on the human Band 3 glycoprotein, the red cell 16 
chloride/bicarbonate anion exchanger (AE1), is highlighted and placed within a structural context. 17 
Recent Findings: The determination of the crystal structure of the membrane domain of human Band 3, 18 
the founding member of the SLC4 family of bicarbonate transporters, is a major breakthrough towards 19 
understanding the mechanism of action of this membrane transport protein, its interaction with partner 20 
proteins, and how mutations linked to disease affect its ability to fold and function.  21 
Summary: Band 3 contains 14 transmembrane (TM) segments arranged in a 7+7 TM inverted repeat 22 
topology common to all members of the SLC4 family and the unrelated SLC26 anion transporter family. 23 
A functional feature of this fold is the presence of a core and a gate domain: the core domain contains 24 
two short TM helices (TM3 and 10) that face each other in the middle of the membrane with the positive 25 
N-terminal helix dipoles creating the anion binding site, while the gate domain forms the dimer 26 
interface. During transport, the movement of these two domains relative to each other provides the 27 
intracellular and extracellular compartments with alternating access to the central anion binding site.  28 
Keywords: anion transport, Band 3, membrane proteins, SLC4, trafficking 29 
 30 
  31 
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Introduction 32 
Band 3, also known as Anion Exchanger 1 (AE1) or Solute Carrier 4A1 (SLC4A1), is responsible for 33 
the electroneutral exchange of chloride and bicarbonate across the red cell membrane, a process 34 
necessary for efficient transport of CO2 during respiration. Band 3 is also important for maintaining red 35 
cell shape, anchoring the actin-spectrin cytoskeleton at the membrane. A truncated kidney anion 36 
exchanger 1 (kAE1), lacking the first 65 residues, is expressed in the basolateral membrane of -37 
intercalated cells, where it plays a role in bicarbonate reabsorption into the blood to facilitate acid 38 
secretion into the urine. Genetic defects in the SLC4A1 gene lead to red blood cell diseases, which 39 
include hereditary spherocytosis (HS), hereditary stomatocytosis (HSt), and Southeast Asian 40 
ovalocytosis (SAO), as well as the kidney disease distal renal tubular acidosis (dRTA). 41 
Human Band 3 is an abundant 911-residue glycoprotein comprised of two domains: an N-terminal 42 
cytosolic domain (cdAE1) that anchors the cytoskeleton at the membrane and interacts with numerous 43 
erythrocyte proteins including deoxyhemoglobin [1] and a C-terminal membrane domain (mdAE1) that 44 
performs anion exchange [2]. Through a cytosolic C-terminal tail, the membrane domain interacts with 45 
carbonic anhydrase II (CAII), which interconverts carbon dioxide and bicarbonate, to form a bicarbonate 46 
transport metabolon [3,4]. Band 3 exists as a mixture of dimers and tetramers in membranes and 47 
detergent solutions [5]. These oligomers form interaction hubs around which integral and peripheral 48 
membrane proteins of the red blood cell are organized [6].  49 
A variety of methods have been used to elucidate the transmembrane topology of Band 3, including 50 
proteolysis, chemical labeling, epitope mapping, scanning N-glycosylation and cysteine mutagenesis, 51 
and fragment-complementation assays [7**]. While these experiments indicated that mdAE1 crosses the 52 
membrane up to 14 times, the topology around putative spans 9 to 12 remained unclear. The crystal 53 
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structure of cdAE1 was determined in 2000 [1], but mdAE1 resisted high-resolution structural analysis 54 
for a further 15 years [8**]. Crystallization of dimeric human mdAE1 (Fig. 1) was enabled by trypsin 55 
cleavage and deglycosylation, use of a monoclonal Fab that bound a conformational epitope, and 56 
locking of the structure in an outward-facing open conformation with H2DIDS, a competitive inhibitor 57 
of anion transport.  58 
The membrane domain of Band 3 has a 7+7 TM inverted repeat structure 59 
The crystal structure of mdAE1 confirmed that Band 3 contains 14 -helical transmembrane (TM) 60 
segments that consist of two inverted seven TM-repeats (TM1 to 7 and TM8 to 14) (Fig. 2a). The TM 61 
segments have a complex topology and are intertwined to form two sub-domains: the core and gate 62 
domains (Fig. 2b). TM1 to 4 and 8 to 11 make up the core domain, and TM5 to 7 and 12 to 14 the gate 63 
domain (Fig. 2c). This folding pattern, known as the 7+7 TM inverted repeat fold [9*], differs from the 64 
major facilitator superfamily (MFS) of transporters that have a much simpler 12 TM topology arranged 65 
in two linear domains (TM1-6 and TM7-12) connected by a cytosolic linker [10,11*].  The 7+7 TM 66 
inverted repeat topology appears to be common to the SLC4 family proteins, as suggested by recent 67 
structures of proteins related to human SLC4A11 [12*,13*]. This fold was first observed in the bacterial 68 
proton-uracil symporter UraA, a member of the SLC23 nucleobase transport family [14*], and 69 
subsequently in the fungal proton-purine symporter UapA [15*] and a bacterial SLC26 anion transporter 70 
[16*].  71 
Helix dipoles comprise the anion binding site 72 
A unique feature of 7+7 TM inverted repeat proteins is the presence of two pseudo-symmetry related 73 
half-helices, TM3 and TM10, that face each other in the middle of the lipid bilayer [9*]. In UraA and 74 
UapA, substrates are bound between the N termini of these two half-helices [14*,15*]. In mdAE1, the 75 
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anion-binding site is also found between the N-terminal ends of TM3 and 10 located in the core domain 76 
(Fig. 3a). The anion is held in place by the positive helical dipoles [17].  Transport also involves Arg730 77 
from TM10 and Glu681 from TM8 (Fig. 3a). Arg730 forms part of the anion-binding site and interacts 78 
with one of the sulfates of H2DIDS, while Glu681 points towards the anion-binding site and may act as 79 
an anionic gate. Consistent with this mode of substrate binding, mutation of Arg748 in mouse Band 3 80 
(equivalent to Arg730) impairs anion transport [18]. Of note, Glu681 has been identified as the proton-81 
binding site for proton-sulfate/chloride exchange by Band 3 [19]. In the sodium-bicarbonate co-82 
transporting members of the SLC4 family, Glu681 is replaced by Asp, suggesting that this Asp likely 83 
provides the sodium-binding site in these proteins [20]. 84 
Disease-causing Band 3 mutations 85 
The crystal structure of mdAE1 revealed the location of a variety of mutations that cause the diseases 86 
HS, HSt, and dRTA [7**]. Many of these mutations cause misfolding and/or aberrant trafficking of the 87 
protein, affecting Band 3 localisation during red cell development or targeting to the basolateral surface 88 
of kidney epithelial cells. While most mutations cause standalone trafficking defects that impact only 89 
one allele and lead to recessive disease, some mutations can lead to mis-trafficking of the wild type 90 
protein by hetero-dimerization causing a dominant disease phenotype [7**]. Band 3 trafficking is also 91 
influenced by additional factors, including Glycophorin A (GPA) and ER chaperones. GPA facilitates 92 
trafficking of Band 3 to the cell surface and can rescue certain Band 3 mutants, including Band 3 SAO 93 
[21]. ER chaperones involved in the folding of glycoproteins, like calnexin, are selectively removed 94 
during terminal erythropoiesis while inhibition of these chaperones in kidney cells can rescue trafficking 95 
of certain kAE1 mutants [22,23]. Specific mutations in Band 3 can cause HSt by inducing cation 96 
passage in the protein; many of these mutations are clustered at the interface between the core and gate 97 
domains near the anion binding site (Fig. 3b) [7**].  98 
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Ion transport mechanism of mdAE1 99 
The core and gate domains are separated by a V-shaped cleft that opens to the extracellular side of the 100 
membrane (Fig. 4a). The substrate-binding site lies at the vertex of the cleft (Fig. 4a), and substrate 101 
passage to this region is blocked when the inhibitor H2DIDS is bound (Fig. 2c). Substrate binding 102 
residues are exclusively in the core domain (Fig. 3a), while the DIDS-reactive Lys539 and Lys851 are in 103 
the gate domain on TM5 and 13, respectively (Fig. 2c).  104 
Anion exchange is achieved through a relative movement of the core and gate domains, providing the 105 
substrates with alternating access to either side of the membrane [24]. While the precise mechanism of 106 
anion transport remains unclear, there are three prevailing models for alternating access (Fig. 4b) [25]. 107 
In the “rocking switch model” both core and gate domains move relative to the lipid bilayer to provide 108 
the alternating access. In the “rocking bundle model” alternating access is accomplished through the 109 
movement of one of the domains against the other, which remains immobile. Finally, in the “elevator 110 
transport model” one domain moves against the other to change the depth of the substrate-binding site in 111 
the membrane. Structures of other 7+7 TM inverted repeat transporters showed that they adopt inward-112 
facing or intermediate occluded conformations, in contrast to the outward-facing mdAE1 113 
[12*,13*,14*,15*,16*,26**]. Thus far, the structure of only one member of the 7+7 TM inverted repeat 114 
family, UraA, has been reported in two states: inward-facing and occluded [26**]. Comparison of these 115 
two conformations suggests a hybrid rocking-bundle elevator mode of transport, in which alternating 116 
access is achieved through a combination of a relative movement of the core against the gate, local 117 
rearrangement within the gate, and concomitant translocation of the substrate. However, a model of 118 
inward-facing mdAE1 built using a technique known as repeat-swap homology modelling, in which the 119 
conformation of the two pseudo-symmetry related repeats are exchanged [27*,28], suggests that mdAE1 120 
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uses only an elevator-like mechanism for anion transport. Further experiments are needed to discern 121 
between the possible modes of transport by mdAE1 and related family members. 122 
The crystal structure provides context for other functional elements of Band 3  123 
The N- and C-terminal regions of mdAE1 are in the cytoplasm and contain two amphipathic -helices, 124 
H1 and H6, that lie along the inner membrane surface (Fig. 4c). H1 (residues 383-401) precedes TM1, 125 
connecting the transmembrane region to the cytosolic domain of Band 3. A nine-amino acid deletion 126 
(Ala401-Ala409) in this region causes SAO [29], potentially altering the relative orientation of the 127 
cytoplasmic and membrane domains. H6 follows TM14 and links it to the C-terminal CAII-interacting 128 
region of Band 3.  129 
The membrane domain of AE1 contains four additional amphipathic -helices (H2-H5) that connect TM 130 
segments (Fig. 4c). H2 lies on the cytoplasmic face of mdAE1 between TM4 and 5 and H3 lies on the 131 
extracellular side between TM11 and 12. Both H2 and H3 connect the core to the gate domain, and the 132 
repeat-swap homology model of inward-facing mdAE1 suggests that H2 and H3 undergo a 133 
rearrangement to facilitate mdAE1 conformational changes during anion transport [27*].  134 
The mdAE1 and cdAE1 can be separated by mild protease treatment of red cell ghosts and are thought 135 
to function independently [2], unlike other SLC4 proteins in which the cytoplasmic domain is required 136 
for activity [30,31]. Analysis of purified bovine Band 3 by negative-stain electron microscopy suggested 137 
that the membrane domain and cytosolic domain are connect by a 3 nm flexible linker [32*]. In contrast, 138 
a model of full-length human Band 3 based on the crystal structures of mdAE1, cdAE1, and zero-length 139 
cross-linking analysis of red blood cell membranes suggested a more compact arrangement within the 140 
intact protein, as well as an interaction between cytoplasmic loops of the membrane domain and the 141 
cytosolic domain [33*]. This interaction is proposed to hold the cytosolic domain in place and out of the 142 
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way of the substrate exit pore on the cytoplasmic side of mdAE1 [33*], supporting the notion that Band 143 
3 does not contain a substrate access tunnel in its cytosolic domain [34].  144 
Interestingly, the presence of a discontinuous SH2 domain in Band 3 that regulates anion transport by a 145 
phosphorylation-dependent mechanism was reported recently [35**]. A conserved phospho-tyrosine 146 
binding motif was detected within H2 that interacts with phosphorylated cdAE1, disrupting Band 3-147 
cytoskeletal interactions and destabilizing the red blood cell membrane. This intramolecular 148 
rearrangement would require that H2 partially unfolds to interact with phosphorylated cdAE1, and is 149 
consistent with the notion that H2, which links the core and gate domains, is involved in conformational 150 
changes associated with anion transport [27*]. Using Syk kinase inhibitors to prevent tyrosine 151 
phosphorylation of Band 3 and increase erythrocyte membrane strength reduced Plasmodium falciparum 152 
egress in parasitized red blood cells, thus providing a potential therapeutic avenue to inhibit malaria 153 
progression [36]. 154 
Band 3 dimer and tetramer structures 155 
The structure of mdAE1 showed that dimerization is mediated exclusively by the gate domain, through 156 
interactions between TM5 and 6 from each subunit, and some residues from TM7, H4, and the loop 157 
connecting H4 to H5 (Fig. 1). Interfacial lipids have been shown to be important for oligomerization of 158 
many membrane proteins [37*] but their role in stabilization of the Band 3 dimer is unclear. While both 159 
UraA and UapA require dimerization for transport activity [15*,26**], studies with inhibitors have 160 
shown that each subunit of Band 3 can operate independently [38]. Indeed, co-expression of wild-type 161 
Band 3 and a non-functional SAO Band 3 mutant results in the surface expression of a heterodimer that 162 
retains almost 50% of wildtype activity [29]. Furthermore, it has been shown that the region around 163 
TM6-7, which is involved in dimerization, was dispensable for Band 3 function [39,40]. 164 
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Band 3 tetramers are dimers of dimers stabilized by binding of ankyrin to each tetramer [5,41]. Cross-165 
linking analysis provides a model for Band 3 tetramer formation involving Glu272 and Lys353 from the 166 
cytosolic domains, and revealed a large interaction interface between Band 3 and ankyrin [33*]. 167 
Additionally, this analysis showed that GPA interacts with cdAE1 [33*], which also interacts with 168 
Glu658 in TM8/9 of mdAE1 to create the Wright blood group antigen [42]. Additional interactions were 169 
proposed for cytosolic loops of mdAE1 with protein 4.1 and protein 4.2, two adaptor proteins involved 170 
in maintaining cytoskeletal interactions. However, the significance of protein 4.2-mdAE1 associations 171 
are unclear as an enhancement effect on Band 3 anion exchange by protein 4.2 was only observed in the 172 
presence of the Band 3 N terminus that contains the main protein 4.2 binding site [43].  173 
Band 3 is a protein interaction hub  174 
The human Band 3 tetrameric macro/multiprotein complex, known as the Band 3 complex in early 175 
literature, consists of a tetramer of Band 3 bound to ankyrin, protein 4.2, and GPA. Ankyrin and protein 176 
4.2 binding to Band 3 facilitates its association to the erythrocyte spectrin cytoskeleton. The Rhesus 177 
protein sub-complex comprising Rh, RhAG, LW, CD47, and Glycophorin B has also been shown to 178 
associate with the tetrameric complex [44]. In contrast, dimeric Band 3 is thought to be either freely 179 
mobile in the membrane or associated within an actin-junctional complex, the composition of which 180 
varies between species [44]. In humans, this junctional complex consists of Band 3 dimers, protein 4.1, 181 
adducin, dematin, GPC, p55, Rh, and also GLUT1 [44,45]. 182 
Several of the integral and peripheral membrane proteins that associate with Band 3 also influence its 183 
function and/or trafficking, such as GPA, which affects both [21]; carbonic anhydrase II, which forms a 184 
metabolon with Band 3 [3]; stomatin, which increased Band 3 transport activity [46]; and protein 4.2, 185 
which increased Band 3-specific chloride influx in Xenopus oocytes [43] but decreased activity in 186 
 10 
reconstituted liposomes [47]. Of note, Aquaporin-1 was recently reported to interact with Band 3 [48], 187 
suggesting the existence of a super-complex involving Band 3, deoxyhemoglobin, CAII, and aquaporin-188 
1 to channel substrates to and from the transporters and their cognate enzyme. How Band 3 associates 189 
with so many proteins, and which regions of Band 3 are involved, still needs to be fully delineated. 190 
However, with many copies of Band 3 (1.2 x 106) available in each cell it is likely that there are many 191 
flavours of Band 3 complexes. 192 
Future prospects 193 
The crystal structures of cdAE1 and mdAE1 have provided valuable molecular insights into Band 3 194 
function and dysfunction, yet the molecular mechanism of substrate transport and Band 3’s interaction 195 
with other proteins remains elusive. Structures of the inward-facing state of mdAE1 would reveal the 196 
extent of the conformational changes associated with transport. A high-resolution structure of intact 197 
Band 3 is needed to show the relative orientation of cytosolic and membrane domains and studies of the 198 
dynamics of this interaction are needed. Single-particle electron cryo-microscopy (cryo-EM), in 199 
particular, holds considerable promise as recent improvements in microscopes and image processing 200 
have led to high-resolution structures of complex membrane transport systems [49,50]. Molecular 201 
dynamics (MD) simulations of Band 3 in complex lipid bilayers will allow the conformational changes 202 
associated with transport to be modelled in a membrane environment [7**]. MD simulations have 203 
recently been used to determine the dynamics the Band 3 TM1 signal-anchor that is responsible for 204 
integrating the protein into the ER membrane [51]. Finally, the Band 3 structure has been used to build 205 
models of other members of the human SLC4 and SLC26 transporter families and to understand the 206 
effect of disease-causing mutations on protein folding and function [7**,52*,53, 54]. We can now look 207 
forward to the challenge of determining how this transporter works at the molecular level and how it 208 
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interacts with the cytoskeleton, GPA, and a multitude of other membrane proteins to build a dynamic 209 
cellular model of Band 3 in action. 210 
Key Points 211 
 The structure of the membrane domain of human Band 3 has revealed the molecular details of the 212 
substrate-binding site and possible mechanisms of anion transport.  213 
 The structure of human Band 3 has allowed localization of disease-causing mutations and 214 
determination of their effect on protein folding and function. 215 
 Models of related SLC4 and 26 transport proteins can be built using the structure of human Band 3 216 
as a template.  217 
 The structure of intact Band 3 still needs to be determined in order to establish the relationship 218 
between the cytoplasmic and membrane domains. 219 
 Band 3 does not operate in isolation but as part of a multi-protein complex integral to the integrity 220 
and function of the red blood cell.  221 
  222 
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Figure Legends 223 
Figure 1. Structure of dimeric of mdAE1. (a-b) Cartoon representation of mdAE1 (PDB ID: 4YZF) 224 
viewed along the plane of the membrane, with H2DIDS removed from the model. The 14 TM helices are 225 
coloured from N-terminus (blue) to C-terminus (red). The dimerization interface is indicated by 226 
asterisks, the anionic substrate by a purple sphere, and substrate passage within subunit B with a grey 227 
arrow.  228 
Figure 2. Structure and topology of monomeric mdAE1 (a) The core domain comprises TM1 to 4 229 
from repeat 1 and TM8 to 11 from repeat 2, which can be superposed on top of each other, while the 230 
gate domain is made up of TM5 to 7 from repeat 1 and TM12 to 14 from repeat 2, which also superpose 231 
well. The TMs and repeats are normally intertwined, but in this figure they are separated for clarity and 232 
the pseudo-symmetry rotation axis is shown (gray circle and arrow). (b) Topology diagram of mdAE1 233 
coloured as in (a). mdAE1 contains a single N-linked glycosylation site at Asn642. (c) Close-up view of 234 
mdAE1 viewed from the extracellular space showing the core and gate domains, with K539 and K851, 235 
from TM5 and 13 respectively, and the crosslinking H2DIDS represented as sticks. 236 
Figure 3. Key residues in the substrate binding site and localization of some disease-causing 237 
mutations. (a) Close-up view of the mdAE1 substrate binding site formed at the N-termini of TM3 and 238 
TM10, which meet in the center of the protein near the middle of the membrane. R730 interacts with one 239 
of the sulfates (*) from H2DIDS. (b) Cartoon loop representation of mdAE1 in the same orientation as 240 
Fig. 2c. Residues mutated in Hereditary Stomatocytosis that induce a cation leak in mdAE1 are 241 
represented by pink spheres. Most of the mutations cluster around the interface of the core and gate 242 
domains of the protein, including within TM10 close to the substrate-binding site. 243 
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Figure 4. The mdAE1 structure provides additional context for Band 3 function. (a) Cross-section 244 
of mdAE1 subunit A (wheat surface colour with grey interior). R730 lies at the vertex of the V-shaped 245 
substrate-binding cleft that is open to the extracellular environment. (b) Schematic of possible 246 
membrane transport mechanisms that allow the molecule to alternate between outward-open and inward-247 
open conformations to provide the substrate (purple sphere) with access to different sides of the 248 
membrane. Yellow arrows indicate domain movements. (c) Cartoon representation of mdAE1 subunit A 249 
with amphipathic -helices that lie parallel to the membrane (H1-H6) colored as in Fig. 1a. 250 
  251 
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